

Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week....
You can purchase shares of AtriCure (NASDAQ:ATRC) through any online brokerage.
There are no as such competitors for AtriCure.
AtriCure has a consensus price target of $55.93.
The stock price for AtriCure (NASDAQ: ATRC) is $61.08 last updated October 26, 2026 at 4:00 PM EDT.
There are no upcoming dividends for AtriCure.
AtriCure does not have any upcoming earnings scheduled.
There is no upcoming split for AtriCure.
AtriCure is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and...